Koninklijke Philips (PHG) Total Non-Current Liabilities (2009 - 2026)

Koninklijke Philips (PHG) recorded quarterly Total Non-Current Liabilities of $9.9 billion in Q1 2026, little changed quarter-over-quarter from $9.8 billion in Q4 2025, and up 7.89% on a YoY basis from $9.1 billion in Q1 2025.

Koninklijke Philips (PHG) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Koninklijke Philips' Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $9.9 billion for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities rose 7.89% year-over-year to $9.9 billion; the TTM figure through Mar 2026 stood at $9.9 billion (up 7.89% YoY), while the FY2025 annual figure was $9.8 billion, up 4.7% from the prior year.
  • Total Non-Current Liabilities was $9.9 billion for Q1 2026 at Koninklijke Philips, roughly flat from $9.8 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $10.2 billion in Q3 2025 to a low of $9.1 billion in Q1 2025.
  • Historically, Total Non-Current Liabilities has averaged $9.7 billion across 5 years, with a median of $9.8 billion in 2025.
  • The sharpest annual moves came in 2022 and 2026: Total Non-Current Liabilities decreased 6.53% in 2022, then climbed 7.89% in 2026.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $9.7 billion in 2022, then grew by 0.86% to $9.7 billion in 2023, then decreased by 3.65% to $9.4 billion in 2024, then advanced by 4.7% to $9.8 billion in 2025, then grew by 0.23% to $9.9 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $9.9 billion (Q1 2026), $9.8 billion (Q4 2025), and $10.2 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 20.94 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 40.52 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 15.78 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 2.44 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.85 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 3.53 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 24.21 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 3.47 Bn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn 9.41 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.85 Bn
Dec 31, 2025 9.83 Bn
Sep 30, 2025 10.20 Bn
Jun 30, 2025 9.93 Bn
Mar 31, 2025 9.13 Bn
Dec 31, 2024 9.39 Bn
Jun 30, 2024 9.47 Bn
Dec 31, 2023 9.75 Bn
Jun 30, 2023 10.10 Bn
Dec 31, 2022 9.66 Bn
Jun 30, 2022 9.92 Bn
Dec 31, 2021 10.34 Bn
Jun 30, 2021 9.93 Bn
Dec 31, 2020 9.63 Bn
Jun 30, 2020 9.93 Bn
Dec 31, 2019 8.21 Bn
Jun 30, 2019 8.19 Bn
Dec 31, 2018 6.80 Bn
Jun 30, 2018 7.16 Bn
Dec 31, 2017 7.57 Bn